Could ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) See a Reversal After Less Sellers Came In?

June 19, 2018 - By Stephen Andrade

The stock of ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) registered a decrease of 18.87% in short interest. ASNB’s total short interest was 12,900 shares in June as published by FINRA. Its down 18.87% from 15,900 shares, reported previously. With 105,000 shares average volume, it will take short sellers 0 days to cover their ASNB’s short positions.

It closed at $0.05 lastly. It is down 0.00% since June 19, 2017 and is . It has underperformed by 12.57% the S&P500.

AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. The company has market cap of $1.08 million. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. It currently has negative earnings. The firm also makes specialty hydrophilic polyurethanes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: